最近的瘤坏死因子-相关的亡-诱导连接体工程策略用于针对瘤的精确打击疗法
Chae Eun Lee1, Kyung Mu Noh1, Sungjun Kim1
1Department of Chemical and Biochemical Engineering, Dongguk University, Seoul 04620, Republic of Korea.
Biomaterials research
|March 20, 2025
概括
开发先进的药物递送系统,如活细胞载体,可以克服与瘤亡因子相关的亡诱导连接体 (TRAIL) 的局限性,以有效治疗癌症. 这些平台增强了TRAIL的功能.
科学领域:
- 生物医学工程 生物医学工程
- 癌症治疗方法 癌症治疗方法
- 药物输送系统 药物输送系统
背景情况:
- 基于蛋白质的疗法,如与瘤亡因子相关的亡诱导配体 (TRAIL),对选择性癌细胞亡有望.
- TRAIL针对死亡受体DR4和DR5,在癌细胞上高度表达,不影响健康组织.
- TRAIL的临床应用受到短半衰期,不稳定性和瘤部位的不良传递的阻碍.
研究的目的:
- 审查开发TRAIL交付平台的新策略,以克服目前的治疗局限性.
- 探索生物材料介导载体,转基因细胞产品,以及用于TRAIL传递的细胞表面工程.
- 讨论临床翻译考量和基于 TRAIL 的癌症治疗方法的未来方向.
主要方法:
- 生物材料介导载体的设计,采用优化的材料,组成,配方和表面调制,以提高准.
- 开发转基因细胞产品,以增加瘤微环境中的 TRAIL 分泌.
- 细胞表面工程的应用,用于在不可融合的细胞群体上进行 TRAIL 固定.
主要成果:
- 基于活细胞的载体显示出系统管理和捕获循环瘤细胞的潜力,防止转移.
- 优化的生物材料载体提高了向效率和药物输送.
- 工程细胞可以增强TRAIL分泌和固定,以改善治疗结果.
结论:
- 新型的TRAIL传递平台,特别是基于活细胞的载体,为癌症治疗提供了显著的优势.
- 解决材料优化,基因改造和细胞工程方面的挑战对于临床翻译至关重要.
- 未来的研究应该专注于补充策略,以推进基于 TRAIL 的癌症治疗方法.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:27Tumor Immunotherapy
454
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
454
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
01:17The Extrinsic Apoptotic Pathway
5.7K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
5.7K
01:31The Intrinsic Apoptotic Pathway
5.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.8K
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K